Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.

MLA

Kim, Albert E., et al. “Abnormal Vascular Structure and Function within Brain Metastases Is Linked to Pembrolizumab Resistance.” Neuro-Oncology, vol. 26, no. 5, May 2024, pp. 965–74. EBSCOhost, https://doi.org/10.1093/neuonc/noad236.

APA

Kim, A. E., Lou, K. W., Giobbie-Hurder, A., Chang, K., Gidwani, M., Hoebel, K., Patel, J. B., Cleveland, M. C., Singh, P., Bridge, C. P., Ahmed, S. R., Bearce, B. A., Liu, W., Fuster-Garcia, E., Lee, E. Q., Lin, N. U., Overmoyer, B., Wen, P. Y., Nayak, L., & Cohen, J. V. (2024). Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance. Neuro-Oncology, 26(5), 965–974. https://doi.org/10.1093/neuonc/noad236

Chicago

Kim, Albert E, Kevin W Lou, Anita Giobbie-Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel, Jay B Patel, et al. 2024. “Abnormal Vascular Structure and Function within Brain Metastases Is Linked to Pembrolizumab Resistance.” Neuro-Oncology 26 (5): 965–74. doi:10.1093/neuonc/noad236.